化学
心肌梗塞
小泡
心脏纤维化
纤维化
膜
细胞
细胞生物学
微泡
心肌纤维化
药理学
细胞膜
内生
癌症研究
HEK 293细胞
生物物理学
信号转导
心室重构
生物相容性材料
组织工程
细胞培养
细胞疗法
受体
再生医学
细胞信号
细胞生长
作者
Haomiao Bai,Guiling Wu,Xinghua Qin,Qilong Yang,Zhihui Yao,Wei Zhang,Jing Wang,Wengang Dong,Lantian Wang,Xing Zhang,Ke Zhou,Jie Deng,Guodong Yang,Jia Li,Bo Peng
标识
DOI:10.1016/j.jpha.2026.101560
摘要
Cardiac fibrosis is a critical pathological process following myocardial infarction (MI), predominantly mediated by transforming growth factor-β1 (TGF-β1), for which effective targeted therapies remain limited. Vasorin is a cell membrane glycoprotein that functions as an endogenous antagonist of TGF-β1. To enhance its binding efficiency, we engineered vasorin variants incorporating site-specific fluorosulfate-L-tyrosine (FSY) through genetic code expansion. This chemical modification enables sulfur-fluoride exchange (SuFEx) reactions and covalent trapping of TGF-β1, thereby improving target selectivity. For lesion-specific delivery, hybrid membrane vesicles (HM-MVP) were constructed by fusing FSY-modified, vasorin-anchored HEK293T cell membranes with thrombus-homing platelet (PLT) membranes. In murine MI models, HM-MVP selectively accumulated within infarcted myocardial tissue and exhibited superior TGF-β1 binding affinity, resulting in more pronounced anti-fibrotic effects compared to native vasorin vesicles. This targeted therapeutic approach was associated with significantly improved cardiac structural preservation and functional recovery post-MI, highlighting favorable drug-like characteristics. Collectively, these findings reveal, for the first time, the cardioprotective and anti-fibrotic potential of vasorin, and elucidate a novel therapeutic paradigm by synergizing FSY-engineered vasorin with biomimetic vesicle delivery to address maladaptive TGF-β1 signaling in cardiac fibrosis. • Vasorin is firstly demonstrated to protect against cardiac fibrosis post-infarction. • Engineering vasorin with FSY strengthens TGF-β1 binding and inhibition. • Hybrid membrane vesicles bearing vasorin-FSY achieve targeted and potent anti-fibrotic effects in infarcted myocardium.
科研通智能强力驱动
Strongly Powered by AbleSci AI